Monitoring photochemical pathogen inactivation treatment using amotosalen and ultraviolet-A light: evaluation of an indicator label

被引：5
|
作者：
Isola, H. [2 ]
Brandner, D. [2 ]
Cazenave, J-P. [3 ]
Stahl, E. [2 ]
Corash, L. [1 ]
机构：
[1] Cerus Corp, Med Affairs, Concord, CA 94520 USA
[2] EFS Alsace, Qual Control, Strasbourg, France
[3] EFS Alsace, Med Affairs, Strasbourg, France
来源：
VOX SANGUINIS | 2010年 / 99卷 / 04期
关键词：
COMPONENT USE; PLATELET; IMPACT;
D O I：
10.1111/j.1423-0410.2010.01372.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：402 / 402
页数：1
相关论文
共 50 条
  • [1] Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial
    Pineda, A
    McCullough, J
    Benjamin, RJ
    Cable, R
    Strauss, RG
    Burgstaler, E
    Porter, S
    Lin, L
    Metzel, P
    Conlan, MG
    [J]. TRANSFUSION, 2006, 46 (04) : 562 - 571
  • [2] Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light
    Lanteri, Marion C.
    Santa-Maria, Felicia
    Laughhunn, Andrew
    Girard, Yvette A.
    Picard-Maureau, Marcus
    Payrat, Jean-Marc
    Irsch, Johannes
    Stassinopoulos, Adonis
    Bringmann, Peter
    [J]. TRANSFUSION, 2020, 60 (06) : 1319 - 1331
  • [3] Pathogen inactivation treatment of triple-dose apheresis platelets with amotosalen and ultraviolet a light
    Infanti, Laura
    Pehlic, Vildana
    Mitrovic, Sandra
    Holbro, Andreas
    Andresen, Silke
    Payrat, Jean-Marc
    Lin, Jin-Sying
    Buser, Andreas
    [J]. TRANSFUSION MEDICINE, 2022, 32 (06) : 505 - 511
  • [4] Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light
    Lin, LL
    Hanson, CV
    Alter, HJ
    Jauvin, V
    Bernard, KA
    Murthy, KK
    Metzel, P
    Corash, L
    [J]. TRANSFUSION, 2005, 45 (04) : 580 - 590
  • [5] In vitro evaluation of pooled buffy coat platelets treated with photochemical pathogen inactivation using amotosalen
    Cazenave, JP
    Aleil, B
    Wiesel, ML
    Laforêt, M
    Isola, H
    [J]. VOX SANGUINIS, 2004, 86 (03) : 201 - 202
  • [6] Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen-reduction technology
    Girard, Yvette A.
    Santa Maria, Felicia
    Lanteri, Marion C.
    [J]. TRANSFUSION, 2020, 60 (03) : 622 - 627
  • [7] The extent of amotosalen photodegradation during photochemical treatment of platelet components correlates with the level of pathogen inactivation
    Liu, Weiqun
    Cimino, George D.
    Corash, Laurence
    Lin, Lily
    [J]. TRANSFUSION, 2011, 51 (01) : 52 - 61
  • [8] Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components
    Grellier, Philippe
    Benach, Jorge
    Labaied, Mehdi
    Charneau, Sebastien
    Gil, Horacio
    Monsalve, Gloria
    Alfonso, Ryan
    Sawyer, Lynette
    Lin, Lily
    Steiert, Matthias
    Dupuis, Kent
    [J]. TRANSFUSION, 2008, 48 (08) : 1676 - 1684
  • [9] Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial
    Snyder, E
    McCullough, J
    Slichter, SJ
    Strauss, RG
    Lopez-Plaza, I
    Lin, JS
    Corash, L
    Conlan, MG
    [J]. TRANSFUSION, 2005, 45 (12) : 1864 - 1875
  • [10] Inactivation of SARS-CoV-2 in All Blood Components Using Amotosalen/Ultraviolet A Light and Amustaline/Glutathione Pathogen Reduction Technologies
    Santa Maria, Felicia
    Huang, Yan-Jang S.
    Vanlandingham, Dana L.
    Bringmann, Peter
    [J]. PATHOGENS, 2022, 11 (05):
12345